Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2021 Oct 7;12:529. doi: 10.1186/s13287-021-02606-0

Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway

Fengyun Zhang 1, Fei Gao 2, Kun Wang 3, Xiaohong Liu 2, Zhuoqi Zhang 1,
PMCID: PMC8499566  PMID: 34620210

Retraction Note to: Stem Cell Research & Therapy (2021) 12:115 10.1186/s13287-021-02183-2

The authors have retracted this article. After publication the authors became aware of issues with two of the figures, specifically:

  • In Fig. 5c the echocardiography images for 1 week and 3 weeks for the MI + HG group had been duplicated owing to an error in the assembly of the figure.

  • In Fig. 3a the bands for Beclin 1 had been constructed by using the bands from P21 in Fig. 2e during assembly of the figure.

All authors agree with this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES